the aid library

LIST OPTIONS

Filter

2797

Sort by:

Direction:

Download (3285)

View PDF (4270)

How To Prevent Disability In Leprosy Part 1
recommended

International Union Against Tuberculosis and Lung Disease (2001) C1

Download (964)

View PDF (1634)

WASH for Schoolchildren in Emergencies: A Guidebook for Teachers

Murat Sahin, Emily Bamford, Lisa Bender et al. UNICEF (2011)

This guidebook for people in school settings is intended to offer strategies for use and adaptation with children and families to re-establish routines of hygiene with basic access to water and sanitation services through an approach that visibly shows that the school is WASHfriendly, inclusive - so... more

Download (262)

View PDF (386)

Standards for Prosthetics and Orthotics. Part 2: Implementation manual

World Health Organization (WHO) (2017) C_WHO

WHO, in partnership with the International Society for Prosthetics and Orthotics (ISPO) and the United States Agency for International Development (USAID), has published global standards for prosthetics and orthotics. Its aim is to ensure that prosthetics and orthotics services are people-centred an... more

Download (291)

View PDF (418)

Country Profile on Disability

Japan International Cooperation Agency Planning and Evaluation Department (2002) CC

Download (470)

View PDF (512)

Including Children with Disabilities in Humanitarian Action - Child protection

United Nations Children's Fund (UNICEF) (2017)

Guidance | Preparedness - Response and early recovery - Recovery and reconstruction

Download (200)

View PDF (915)

Deinstitutionalisation – A Human Rights Priority for Children with Disabilities

Georgette Mulheir (2012) CC

The Equal Rights Review Volume 9, pp.117-137

Download (131)

View PDF (195)

Needs and barriers for mental health and psychosocial support among syrian refugees in lebanon: perspectives for future interventions

European Union Civil protection and Humanitarian Aid European Union Civil protection and Humanitarian Aid (2018) CC

Results Recommendations• NGOs should provide MHPSS services with a focus on empowerment and self-reliance • Introduce interventions focusing on pain mechanisms, coping strategies and physical resilience • Implement livelihood programmes • Increase service accessibility and outreach activ... more

Download (240)

View PDF (454)

Disability, Human Rights and Sustainable Development

Christoffel-Blindenmission (CBM) (2016) CC

Infographic

Download (153)

View PDF (329)

What works? Promoting the rights of disabled children

Gerison Lansdown Rights for Disabled Children (2003) C2

Guidelines for action

Download (243)

View PDF (395)

Brochure: Ear and Hearing Care & Education of persons who are deaf, hard of hearing or deafblind

Christoffel Blinden Mission (CBM) Christoffel Blinden Mission (CBM) (2015)

Download (234)

View PDF (281)

WHO consolidated guideline on self-care interventions for health: sexual and reproductive health and rights

World Health Organization WHO (2019) C_WHO

Self-care interventions are among the most promising and exciting new approaches to improve health and well-being, both from a health systems perspective and for people who use these interventions. The World Health Organization (WHO) uses the following working definition of self-care: Self-care is t... more

Download (448)

View PDF (641)

Vietnam: Disaster Management Reference Handbook

Center for Excellence in Disaster Management and Humanitarian Assistance (2015) C1

The National Strategy for Natural Disaster, Prevention, Response and Mitigation to 2020, which outlines Vietnam’s main disaster risk management objectives and the National Target Program (NTP) form the overarching policy framework for disaster risk management and climate change adaption activities... more

Download (277)

View PDF (595)

Situation Analysis of Children in South Africa

United Nations Children's Fund (UNICEF) (2009)

Download (208)

View PDF (399)

Standards for Prosthetics and Orthotics. Part 1: Standards

World Health Organization (WHO) (2017) C_WHO

Download (516)

View PDF (466)

Compilation of community-based rehabilitation practices in the WHO South-East Asia Region

World Health Organization WHO, Regional Office for South East Asia (2013) C_WHO

Download (93)

View PDF (122)

WHO Guideline on self-care interventions for health and well-being

World Health Organization WHO (2021) C_WHO

Download (77)

View PDF (324)

Mycetoma: epidemiology, treatment challenges, and progress

Taha, H.; Fahal, A.; Van de Sande, W. Dovepress open access to scientific and medical research (2015) CC

Mycetoma is a specific chronic, granulomatous, inflammatory disease. It usually involves the subcutaneous tissue, most probably after traumatic inoculation of the causative organism. It has a prolonged, progressive, and indolent course, and, if untreated, it ultimately leads to destruction of the de... more

Download (84)

View PDF (482)

Global programme to eliminate lymphatic filariasis: progress report, 2020 - Weekly Epidemiological Record, 2021, vol. 96, 41 [‎full issue]‎

World Health Organization WHO; Institutional research information sharing iris (2021) C_WHO

Lymphatic filariasis (LF) is an avoidable, debilitating, disfiguring disease caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi and B. timori. Globally, 51.4 million people are estimated to be infected. Lymphoedema and hydrocoele are the visible, chronic clinical co... more

Download (239)

View PDF (322)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (8)

View PDF (9)

Screening for cardiovascular disease risk and subsequent management in low and middle income countries: challenges and opportunities

Bovet, P.; Chiolero, A.; Paccaud, F. et al. Public Health Reviews (2015) CC

Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the leading cause of premature mortality in low and middle income countries (LMICs). Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector... more

How To Prevent Disability In Leprosy Part 1 recommended

How To Prevent Disability In Leprosy Part 1
recommended